Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasms, version 2.2017: Clinical practice guidelines in oncology
    Journal Article

    Mesa, R.; Jamieson, C.; Bhatia, R.; Deininger, M. W.; Gerds, A. T.; Gojo, I.; Gotlib, J.; Gundabolu, K.; Hobbs, G.; Klisovic, R. B.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis
    Journal Article

    Poulos, M. G.; Ramalingam, P.; Gutkin, M. C.; Kleppe, M.; Ginsberg, M.; Crowley, M. J. P.; Elemento, O.; Levine, R. L.; Rafii, S.; Kitajewski, J.; more...
    Nature Communications (2016)

    Fulltext@MSK | Save
  • Acute myeloid leukaemia
    Journal Article

    Khwaja, A.; Bjorkholm, M.; Gale, R. E.; Levine, R. L.; Jordan, C. T.; Ehninger, G.; Bloomfield, C. D.; Estey, E.; Burnett, A.; Cornelissen, J. J.; more...
    Nature Reviews Disease Primers (2016)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia
    Journal Article

    Boyiadzis, M.; Bishop, M. R.; Abonour, R.; Anderson, K. C.; Ansell, S. M.; Avigan, D.; Barbarotta, L.; Barrett, A. J.; Besien, K.; Bergsagel, P. L.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Tyrosine 625 plays a key role and cooperates with tyrosine 630 in MPL W515L-induced signaling and myeloproliferative neoplasms
    Journal Article

    Yu, C. J.; Yang, Q.; Chen, Y. H.; Wang, D. M.; Levine, R.; Crispino, J.; Wen, Q.; Huang, Z.
    Cell and Bioscience (2016)

    Fulltext@MSK | Save
  • Armored CAR T-cells: Utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
    Journal Article

    Yeku, O. O.; Brentjens, R. J.
    Biochemical Society Transactions (2016)

    Fulltext@MSK | Save
  • Final phase IIa study results evaluating the CXCR4 antagonist BL-8040 in combination with cytarabine (Ara-C) for the treatment of relapsed/refractory AML patients
    Meeting Abstract

    Borthakur, G.; Tallman, M.; Ofran, Y.; Foran, J.; Uy, G.; DiPersio, J.; Nagler, A.; Rowe, J.; Showel, M.; Altman, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • A chart review of lower dosing of ponatinib in patients with chronic myeloid leukemia (CML): Preliminary findings
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • The PACE clinical trial vs the real-world: Comparison of ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save